CME to start trading benzine futures next month
"Chemical futures trading is a new frontier in the derivatives sector," said CME chairman Scott Gordon. "These new futures contracts represent a new line of risk management tools."
His comments were echoed by CheMatch president Larry McAfee, who said: "The ability to hedge intermediate and downstream products using regulated futures is an important milestone for the chemical industry."
Benzene and mixed xylenes are essential components in a number of industries, including the plastics business, and prices can at times be volatile.
Each CME-CheMatch futures will represent 42,000 gallons of the benzene or xylene and will be cash settled at contract expirations to an index of monthly prices compiled by Houston-based petroleum consulting firm DeWitt & Company.
CheMatch's strategic investors include venture capitalist firm Battery Ventures, along with leading chemical firms like Bayer, DuPoint, Methanex and Milllennium Chemicals, among others.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact [email protected] to find out more.
You are currently unable to copy this content. Please contact [email protected] to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
More on Exchanges
Regulation
UMR efficiency: optimising systems and processes for IM compliance
UMR are among the biggest collateral management issues faced by investors in over-the-counter (OTC) derivatives. At a specially convened session sponsored by IHS Markit at Risk.net’s Buy-Side Risk Global event, panellists discussed the latest phases of…
Receive this by email